Lung cancer is the leading cause of cancer deaths in Taiwan ([@bib27]) and worldwide ([@bib35]). Patients with lung cancer often experience sleep disturbances during and after treatment ([@bib11]) with a prevalence of 45--57% ([@bib19]; [@bib11]). Sleep disturbances can affect the quality of life ([@bib19]) and even the prognosis ([@bib37]) of patients with lung cancer as well as disrupt their rest-activity rhythms ([@bib23]). In general, sleep quality is subjectively assessed using the Pittsburgh Sleep Quality Index (PSQI), in which a score of \>5 indicates poor sleep quality ([@bib8]). Furthermore, sleep quality can be objectively assessed through actigraphy: sleep disturbance is indicated by a total sleep time (TST) of ⩽6.5 h ([@bib22]), sleep efficiency (SE) of ⩽85% ([@bib13]), sleep onset latency (SOL) of \>30 min ([@bib17]), or wake after sleep onset (WASO) of \>30 min ([@bib34]). Factors including age ([@bib21]; [@bib10]), sex, marital status ([@bib1]), cancer stage, and anticancer treatments ([@bib33]; [@bib10]), which can affect sleep quality, must be included in sleep quality assessments for cancer patients. Unstable rest-activity rhythms lead to sleep disturbance ([@bib26]; [@bib2]), and non-small-cell lung cancer patients with disrupted rest-activity rhythms may experience poor sleep quality and insomnia ([@bib23]).

A cross-sectional study, using actigraphy to measure objective sleep quality and assess rest-activity rhythms in patients with lung cancer, reported more favorable TST, SE, SOL, 24-h autocorrelation coefficient (r24), and in-bed less than out-of-bed dichotomy index (I\<O) data in patients performing light physical activities for at least 295 min/day than in those performing these activities for \<295 min/day ([@bib10]). In addition, I\<O is a predictor of TST and SOL ([@bib10]). These results indicate a strong correlation among physical activity, sleep quality, and rest-activity rhythms. Thus, exercise may stabilise rest-activity rhythms and improve sleep quality ([@bib14]).

Few studies---most with small sample sizes---have reported the positive effects of exercise on rest-activity rhythms. Furthermore, providing healthy adults with an exercise regimen can improve their sleep-wake cycle ([@bib38]). Some exercise intervention studies have reported that exercise can improve the sleep quality of patients with lung or colorectal cancer ([@bib12]), breast cancer, and other cancer types ([@bib39]; [@bib32]). However, other studies have found that exercise improves the subjective but not objective sleep quality of patients with cancer ([@bib39]). Thus, the effects of exercise on sleep disturbances in patients with cancer remain unclear, possibly because of the inconsistency among previous studies regarding the type, intensity, frequency, and duration of exercise regimens and the diversity of assessment methods used.

This study investigated (1) the effect of a 12-week walking exercise program in improving subjective and objective sleep quality and stabilising rest-activity rhythms and (2) the moderating effect of rest-activity rhythms on subjective and objective sleep quality among patients with lung cancer.

Materials and methods
=====================

Study design and participants
-----------------------------

The present research is a substudy of a larger research project; some of the findings have been published previously ([@bib9]). This was a randomised controlled trial, comprising a walking exercise group that received a 12-week regimen of home-based walking exercises and another group that received usual-care. Data were collected using a questionnaire, and the measurements of rest-activity rhythms and sleep quality were collected at three time points \[pretrial (T1), after 3 months (T2), and after 6 months (T3)\]. This study was approved by the Taipei Veterans General Hospital\'s Institutional Review Board, and consent was obtained from all participants.

Participants were recruited from a medical center in Northern Taiwan. Patients with lung cancer who were aged ⩾18 years, could communicate in either Mandarin or Taiwanese, and were not cognitively impaired were included. By contrast, those performing regular exercise, having congestive heart failure, or having orthopedic disorders of the lower limbs were excluded.

Procedure
---------

Patients who visited the pulmonary medicine or thoracic surgery outpatient department and agreed to participate in this study were referred to the researchers. After the patients signed the consent form, we instructed them on how to complete the T1 questionnaire, comprising a survey of demographic data, the PSQI questionnaire, a sleep diary, and a 3-day physical activity record. Participants were provided actigraphs to be worn on their nondominant arm and then asked to take home the physical activity record questionnaire and record their physical activities. Finally, participants were provided a shockproof envelope for returning the actigraph and physical activity record, through registered mail. After completing the initial steps, by using computer-randomised group assignment, we determined assigned participants to walking exercise or the usual-care. Follow-up data 3 (T2) and 6 (T3) months after intervention were collected using the questionnaires and actigraphs (please see the '[Supplementary Material A](#sup1){ref-type="supplementary-material"}: Study calendar\' for the details).

Interventions
-------------

A 12-week regimen of home-based walking exercises, comprising walking at a moderate intensity for 40 min, three times a week, was administered along with weekly exercise counseling. After collecting pretrial measurements, we explained the participants how to perform the exercises, according to an instruction manual for the exercise regimen. The detailed instructions, provided at the hospital clinics, included the determination of activity intensity, demonstration of pulse measurement, criteria for scores of 6--20 on the Borg\'s rating of perceived exertion (RPE; [@bib5]), prevention of exercise-related injuries, and conditions necessitating termination of an exercise session. Participants were instructed that the exercises would be effective only if they reached 60--80% of the target heart rate, as determined by the Karvonen method ([@bib20]), and 13--15 on the RPE.

For each participant, we discussed exercise regimen-related issues weekly through the telephone. For instance, we discussed whether participants\' exercise fulfilled the prescribed intensity, duration, or frequency and whether the participants experienced any adverse effects. If a patient had not exercised for ⩾3 days and we determined that this lack of exercise was not due to adverse effects of exercising, we reiterated the exercise instructions and encouraged the patient to continue the regimen. The participants were reminded to record their activity after every session and were instructed that after completing the regimen in 3 months, we would collect the record of physical activities for calculating the regimen completion rates (Please see the '[Supplementary Material B](#sup1){ref-type="supplementary-material"}: Instructions for the home-based walking exercise program\' for details).

The usual-care group
--------------------

The usual care group was provided services similar to those provided to the walking exercise group depending on their treatment (e.g., postoperative care, chemotherapy care, and outpatient department follow-up), except for the 12-week regimen of home-based walking exercise training and weekly telephone exercise counseling. The patients were asked to maintain normal daily activity and not perform additional exercise during the study period. For ethical considerations, we mailed the exercise booklet to the participants and offered exercise counseling at the end of the study.

Measures
--------

### Subjective sleep quality

We used PSQI ([@bib8]), comprising 19 items, with each score ranging from 0 to 3 and a total score range of 0--21. A score of 0 indicated no sleep problems and 3 indicated serious sleep problems. Because of its widespread use, PSQI has been translated into a Taiwanese version (PSQI-T). The reliability of PSQI-T---measured using Cronbach\'s α---is 0.79, and the test-retest reliability---measured using 16 patients who took a retest 20--28 days later---is 0.91 ([@bib36]).

### Objective sleep quality

An actigraph (Ambulatory Monitoring, Ardsley, NY, USA) was worn on patients\' nondominant arms to collect data continuously for 72 h. Sleep parameters included TST, SE, SOL, and WASO. The Micro-Mini Actigraph and the Action W2 analysis software have high validity, with an internal consistency of 91% for minute-by-minute synchronised measurements using polysomnography ([@bib15]). Using the zero cross mode to sample patient data at 1-min epoch intervals is sufficient for analyzing a patient\'s sleep and activities for 3 consecutive days ([@bib24]). The Act Millennium software (Ambulatory Monitoring) was first used to download the data from the actigraph. Subsequently, the Action W2 software was used to process and calculate parameters, including TST, SE, SOL, and WASO ([@bib13]; [@bib22]; [@bib17]; [@bib34]), by using the Cole-Kripke algorithm ([@bib15]). Patients\' sleep diaries were used to corroborate bedtime and wake times ([@bib4]). Clinical sleep specialists ([@bib7]) have suggested that objective sleep indicators are more appropriate for assessing sleep disturbance. A sleep diary was recorded concurrently with the actigraph readings to confirm the exact bedtimes and wake times ([@bib4]). The patients were asked to record the duration for which they took off the actigraph in the sleep diary to help the researcher define missing data and discard them. If the patients forgot to record it, the actigraphy analyst sought confirmation from the patients through the telephone. Data cleaning was performed before analyzing the actigraph data. Data processing and actigraph reading analysis were conducted by a researcher experienced in managing actigraph data ([@bib24]).

### Rest-activity rhythms

An actigraph was worn by the patients to collect data continuously for 72 h ([@bib24]). Rest-activity rhythm parameters, namely r24 and I\<O, were measured. All settings and analysis procedures were identical to those described in the Objective sleep quality subsection, except the data were exported to the Action 4 software (Ambulatory Monitoring) for analyzing rest-activity rhythms. r24 is a ratio that quantifies the regularity and consistency of activity between one day and the next day ([@bib3]). The value of this indicator ranges from −1 to 1, with a higher value representing more stable and regular rest-activity rhythms ([@bib16]; [@bib29]). I\<O is the percentage of activity counts per minute when the patient is in bed, and it is lower than the median activity count when the patient is out of bed during the day ([@bib28]). An analysis of I\<O requires the patient\'s sleep diary to validate the patient\'s bedtimes and wake times ([@bib29]), and the value of this indicator ranges from 0% to 100%. A patient with high sleep quality at night and a high level of physical activity during the day will exhibit a prominent, strong circadian rhythm, and I\<O will be close to 100% ([@bib29]; [@bib31]). Before commencing the study, the aforementioned researcher defined data as missing when a participant did not wear the actigraph for more than 1 h ([@bib4]) and then discarded the missing data while analyzing r24.

### Physical activity

Physical activity was assessed to determine contamination by the control group. Physical activity was assessed through actigraphy and by using the Bouchard 3-day physical activity record. The up activity mean was recorded through actigraphy during waking hours for 72 h continuously, along with rest-activity rhythms. The original physical activity record comprises activities recorded by the patient on two weekdays and one weekend day and is used to calculate energy expenditure ([@bib6]). The 3-day physical activity record has been translated and adapted for Taiwanese culture ([@bib25]). The reliability and validity of the adapted version was tested in Taiwan by using the TriTrac-R3D accelerometer. The results showed a satisfactory test-retest reliability and criterion-related validity of 0.95 and 0.81, respectively. Although the 3-day physical activity record is typically used to calculate daily energy expenditure ([@bib6]), we used it to determine the physical activity minutes in the present study. After the patients completed recording the activities undertaken for 2 weekdays and 1 weekend day, we used the record to calculate the 3-day sum and mean minutes of light, moderate, and vigorous activities for each participant.

Statistical analyses and sample size calculations
-------------------------------------------------

According to the results of eight participants in the pilot study, the mean \[standard deviation (SD)\] PSQI scores of the walking exercise and usual-care groups were 7.25 (4.99) and 8.50 (4.51), respectively, after the 12-week home-based walking exercise program. The sample size was estimated to be 40 patients per group by using the G\*Power software (Version 3.1.0; [@bib18]) for repeated measures, with a significance level of 0.05, effect size of 0.26, power of 0.8, and correlation of 0.8. On the basis of an assumed dropout rate of 30%, the enrollment of 104 patients was considered adequate.

We used an intention-to-treat approach for analysis. The *t* test or chi-square test was used to determine the differences in the baseline values between the two groups. We used a general linear model for evaluating the mean values, SDs, and differences between group outcomes at the baseline and 3 and 6 months after intervention. Generalised estimating equations (GEEs) were used for testing group differences with respect over time. A GEE model was used to test the moderating effect of the rest-activity rhythm indicators (r24 and I\<O) on the subjective (PSQI) and objective (TST, SE, SOL, and WASO) indicators of sleep quality. All tests involved a two-sided significance level of α=0.05. All statistical analyses were conducted using the IBM Statistical Package for the Social Sciences (version 20) for Windows (IBM, Somers, NY, USA).

Results
=======

Study population and baseline data
----------------------------------

We recruited 111 patients with lung cancer, aged 37--88 years, between March 2010 and March 2015. The demographic data and disease characteristics of the walking exercise and routine care groups did not differ significantly (*P*\>0.2 for all tests; [Table 1](#tbl1){ref-type="table"}). Nevertheless, pretrial r24 and moderate-intensity physical activity minutes differed significantly between the two groups.

Protocol adherence
------------------

Among the 111 patients, 56 and 55 were randomly assigned to the walking exercise and rusual-care groups, respectively. Pretrial data and PSQI were collected for all participants; however, the actigraph data were missing for six participants because the participants forgot to wear the actigraph or the actigraph malfunctioned. After 6 months, 89 participants remained (80.2% [Figure 1](#fig1){ref-type="fig"}). Among all participants, 87 submitted measurements at all three collection time points (78.4%) and 24 submitted measurements at only one or two collection time points (21.6%). No significant difference was found between the walking exercise and usual-care groups in terms of completing the measurements. Thirteen participants in the walking exercise group (23.2%) and nine in the usual-care group (16.4%) dropped out of the study; this difference was not significant. The demographic factors, disease characteristics, and pretrial outcomes (PSQI, TST, SE, SOL, WASO, r24, and I\>O) of participants who submitted measurements at all three collection time points and participants who did not complete or withdrew from the study did not differ significantly; further analysis using Little\'s test of missing completely at random also showed that the results were nonsignificant (χ^2^=380.17, *P*=0.307).

The participants in the walking exercise group completed an average of 21 walking exercise sessions (SD=43.99). The median number of completed sessions was 24; 24 participants (42.9%) completed all 36 scheduled exercise sessions within 3 months, whereas 31 (55.4%) completed at least two or three of the exercise sessions. All participants completed an average of 58.2% sessions. Reasons for not completing all 36 sessions included dropping out from the study (*n*=13), feeling unwell (*n*=9), losing interest (*n*=6), or being busy (*n*=4).

In the walking exercise group, the mean amount of moderate-intensity physical activity was 8 min/day at the baseline and 28 and 10 min/day at 3 and 6 months after intervention, respectively. In the usual-care group, the mean amount of moderate physical activity was 29 min/day at the baseline and 37 and 46 min/day at 3 and 6 months after intervention, respectively. We also noted that the interaction term *group difference* × *time* was not statistically significant in the GEE model (Wald χ^2^=1.977, *P*=0.372). In addition, through disclosures and the physical activity record data for the 3- and 6-month measures, we noted that in the usual-care group, three participants performed biking activities, two hiked, and one walked slowly, all for at least 1 h/day.

Effects of walking exercises on subjective and objective sleep quality and rest-activity rhythms
------------------------------------------------------------------------------------------------

Because of the significant differences in the pretrial r24 and moderate-intensity physical activity minutes between the walking exercise and usual-care groups, these two variables were controlled using GEEs to analyze the effect of walking exercises on subjective and objective sleep quality and rest-activity rhythms. The walking exercise group had significantly improved subjective sleep quality (lower PSQI scores) compared with the usual-care group over time (Wald χ^2^=15.16, *P*=0.001; [Table 2](#tbl2){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"}). Nevertheless, although both groups scored \>5 on the PSQI, indicating disturbed sleep, the walking exercise group had improved scores by 3 points, whereas the usual-care group showed no change in their sleep quality. In addition, the walking exercise group had significantly improved objective sleep quality (increased TST) compared with the usual-care group over time (Wald χ^2^=7.59, *P*=0.023; [Table 2](#tbl2){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"}), indicating that walking can effectively increase TST as well. These results demonstrated a significantly positive effect of walking exercises on the subjective and objective sleep quality of the patients with lung cancer.

No significant differences over time were observed for other indicators of objective sleep quality (SE, SOL, and WASO) and rest-activity rhythms (r24 and I\>O). However, SOL at 6 months after intervention was significantly lower in the walking exercise group than in the usual-care group (23 min *vs* 38 min, *P*=0.045; [Table 2](#tbl2){ref-type="table"}).

We further analyzed the intervention effects of walking exercises on the PSQI, TST, SE, SOL, WASO, r24, and I\<O, according to the clinical cutoff values ([@bib13]; [@bib8]; [@bib22]; [@bib17]; [@bib34]). We observed no significant differences in the indicators of subjective sleep quality (PSQI), objective sleep quality (TST, SE, SOL, and WASO) and rest-activity rhythms (r24 and I\>O) over time ([Supplementary Table 2](#sup1){ref-type="supplementary-material"}).

Moderating effects of rest-activity rhythms on subjective and objective sleep quality
-------------------------------------------------------------------------------------

The GEE model was used to examine the moderating effects of rest-activity rhythms on subjective and objective sleep quality. In the TST model, I\<O and group had a significant interaction effect (β=3.70, *P*=0.032; [Supplementary Table 1](#sup1){ref-type="supplementary-material"}), thus indicating that walking exercises may amplify or diminish the objective sleep indicator TST depending on I\<O of different rest-activity rhythms. Furthermore, in the PSQI model, I\<O and group had a nearly significant interaction effect (β=−0.13, *P*=0.050; [Supplementary Table 1](#sup1){ref-type="supplementary-material"}). To comprehensively understand the beneficial effects of walking exercises on patients on the basis of their rest-activity rhythms, we classified r24 and I\<O as low, average, or high depending on their percentiles ([@bib29]). Walking exercises significantly improved subjective sleep quality (reduced PSQI scores) and objective sleep quality (increased TST) over time in the walking exercise group with poor rest-activity rhythm of r24 (⩽0.30), and this effect was more evident in the walking exercise group than in the usual-care group. In the GEE model, after adjustment for the significant differences in I\<O between the walking exercise and usual-care groups, the interaction term *group difference × time* was statistically significant (PSQI: Wald χ^2^=9.33, *P*=0.009; TST: Wald χ^2^=9.44, *P*=0.009; [Table 3](#tbl3){ref-type="table"} and [Figure 3](#fig3){ref-type="fig"}); *group difference × time* was not significant ([Table 3](#tbl3){ref-type="table"}) compared with that of participants with favorable r24 (⩾0.46).

Walking exercises significantly improved subjective sleep quality (reduced PSQI scores) over time in the walking exercise group participants with poor rest-activity rhythm of I\<O (⩽96.93), and this effect was more prominent in the walking exercise group than in the usual-care group. In the GEE model, after adjustment for the significant differences in PSQI scores between the walking exercise and usual-care groups, the interaction term *group difference × time* became significant (Wald χ^2^=30.84, *P*\<0.0001). In addition, walking exercises slightly improved objective sleep quality (increased TST) over time for the walking exercise group participants with poor rest-activity rhythm of I\<O (⩽96.93), and this effect was more prominent in the walking exercise group than in the usual-care group. In the GEE model, after adjustment for the significant differences in PSQI scores between the walking exercise and usual-care groups, the interaction term *group difference × time* was nearly significant (Wald χ^2^=5.44, *P*\<0.066) but remained nonsignificant ([Table 3](#tbl3){ref-type="table"}) compared with that of participants with favorable I\>O (⩾97.35). For further examination, we considered 0.42 and 97% to be cutoff values for r24 and I\<O, respectively ([@bib29]). Walking exercises still significantly improved subjective sleep quality (reduced PSQI scores) and objective sleep quality (increased TST) over time in the walking exercise group with poor r24 (⩽0.42) and poor I\<O (⩽97; [Supplementary Table 3](#sup1){ref-type="supplementary-material"}). Thus, walking exercises more effectively improved the subjective and objective sleep quality---as assessed using PSQI scores and TST---of lung cancer patients with poor rest-activity rhythms than of those with favorable rest-activity rhythms.

Adverse events
--------------

During the study period, one participant in the walking exercise group was hospitalised for shortness of breath and hematuria; nevertheless, the walking exercises were eliminated as the cause. In addition, one participant in the usual-care group was hospitalised for an altered state of consciousness caused by brain metastasis.

Discussion
==========

This study is the first to verify that home-based walking exercises can improve the subjective and objective sleep quality and rest-activity rhythms of patients with lung cancer. This finding is similar to that of previous studies on patients with colorectal, breast, and other types of cancer ([@bib39]; [@bib32]), indicating that the effect of exercise on improving sleep quality among patients with lung cancer is similar to that among patients with other cancers. However, we observed that the exercises did not stabilise rest-activity rhythms. This result is similar to that of a small-scale study on healthy adults, which reported that a 4-day short-term regimen of moderate-intensity stationary bicycle exercises induced phase-advance shifts but did not affect the circadian rhythm of plasma melatonin levels ([@bib38]). Additional studies are required to determine whether exercise interventions conducted for a longer duration (e.g., ⩾3 months) or at a specific time of day alter or adjust rest-activity rhythms. In the present study, the overall effects of the exercise intervention on rest-activity rhythms in 111 participants were nonsignificant. However, independent analyses of groups of participants with poor rest-activity rhythms, that is, those with poor r24 or I\<O, showed that exercise significantly improved both PSQI scores and TST, thus confirming that exercise can improve and maintain improvements in subjective and objective sleep quality of lung cancer patients with poor rest-activity rhythms.

The results of the present study support another initial assumption that circadian rhythms have a moderating effect on the subjective and objective sleep quality of patients with lung cancer. The results showed that walking exercises more effectively improved the subjective and objective sleep quality of lung cancer patients with poor rest-activity rhythms, as assessed using the PSQI and TST. For example, in the walking exercise group, PSQI scores significantly decreased by 4.27 points (from 12.27 points at the baseline to 8.0 points at 6 months) in the poor I\<O subgroup (I\<O value⩽93.96) and by only 2.87 points (from 7.82 points at the baseline to 4.95 points at 6 months) in the favorable I\<O subgroup (I\<O value⩾97.35; [Table 3](#tbl3){ref-type="table"}). Furthermore, in the walking exercise group, the TST value significantly increased by 40.84 min (from 327.45 min at the baseline to 368.29 min at 6 months) in the poor I\<O subgroup (I\<O value⩽93.96) and decreased by 8.67 min (from 434.14 min at the baseline to 425.47 min at 6 months) in the favorable I\<O subgroup (I\<O value⩾97.35; [Table 3](#tbl3){ref-type="table"}). This suggests that rest-activity rhythms may be involved in poor sleep quality. Studies have reported that the amplitude of rest-activity rhythms and indicators of subjective and objective sleep quality (e.g., TST and SE) are negatively correlated; in other words, people with unstable or unapparent rest-activity rhythms exhibit poor sleep quality ([@bib2]). We recommend that future intervention studies include rest-activity rhythms as moderating variables. In addition, examining the rest-activity rhythm indicators r24 and I\<O may provide a clearer understanding of a patient\'s overall sleep quality.

Although we performed randomisation in our study, the mean amount of moderate-intensity physical activity in the usual-care group still higher than the walking exercise group. We discovered, through their disclosure or 3-d PAR, that 3 participants in the usual-care group biked for at least one hour per day, 2 participants hiked at least one hour per day, and one participant walked slowly for at least one hour per day. The research ethics prohibited us from limiting the activities of the participants in the usual-care group. In particular, patients with lung cancer who have experienced the struggle between life and death have a strong desire for maintaining a healthy lifestyle and aspire to become ardent pursuers of better health. Studies have reported that patients often adjust their lifestyles after receiving a diagnosis of cancer and during cancer treatment. They are particularly likely to increase physical activity to alleviate their illness or improve their overall health ([@bib30]). This difference between the two groups on the mean amount of moderate-intensity physical activity can be attributed to the small sample size.

The present study has some limitations. First, we could not perform a blind study. The patients were informed regarding the exercise regimen; thus, patients may have experienced the placebo effect, leading to observation bias. To reduce the risk of observation bias, a standardised procedure, conducted by the same personnel with the same equipment and interview guide for data collection, should be devised. In addition, telephone counseling for the usual-care group similar to that received by the walking exercise group (such as weekly nutrition counseling) should have been performed, because they would have reduced the risk of the placebo effect in the walking exercise group caused by a difference in the number of counseling telephone calls received. Second, because of the time limit, we only concluded that 12 weeks of exercise causes a nonsignificant effect on rest-activity rhythms. We suggest that future studies should employ a longer period for exercise training. Third, three participants in the usual-care group performed exercise activities, which may have led to an underestimation of the effect of the exercise intervention. Fourth, contamination in the usual-care group may exist in this study.

In summary, the present study was the first to verify that a regimen of home-based walking exercises is an effective intervention for patients with lung cancer. The study results demonstrated that home-based walking exercises can effectively improve the subjective and objective sleep quality of patients with lung cancer, particularly those with poor rest-activity rhythms. Healthcare providers should recognise the benefits of exercise and incorporate it as a key component of lung cancer care and rehabilitation.
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![**Consolidated standards of reporting trials (CONSORT) diagram showing the flow of participants through the trial.**](bjc2016356f1){#fig1}

![**Effects of walking exercise on subjective and objective sleep quality in both groups.** (**A**) PSQI scores decreased and (**B**) TST increased in the walking exercise group over time. PSQI, Pittsburgh Sleep Quality Index; TST, total sleep time.](bjc2016356f2){#fig2}

![**Subjective and objective sleep quality in the r24 and I\<O subgroups.** The trends of changes in (**A**) the PSQI and (**B**) TST in the poor r24 subgroup and in (**C**) the PSQI and (**D**) TST in the poor I\<O subgroup. I\<O, in-bed less than out-of-bed dichotomy index; PSQI, Pittsburgh Sleep Quality Index; r24, 24-h autocorrelation coefficient; TST, total sleep time.](bjc2016356f3){#fig3}

###### Demographic data and disease characteristics of all participants categorised into walking exercise and usual-care groups (*N*=111)

                                                             **Walking exercise group** ***n*****=56**   **Usual-care group** ***n*****=55**   ***P***[a](#t1-fn1){ref-type="fn"}
  --------------------------------------------------------- ------------------------------------------- ------------------------------------- ------------------------------------
  **Age (years)**                                                                                                                             
  Mean (SD)                                                                64.64 (11.54)                            62.51 (9.64)                             0.284
  Median                                                                       67.00                                    62.00                                   
  Range                                                                       37--83                                   40--81                                   
  **Education (years)**                                                                                                                       
  Mean (SD)                                                                10.71 (4.77)                             10.71 (4.45)                             0.995
  **Sex (n, %)**                                                                                                                              
  Male                                                                       24 (42.9)                                25 (45.5)                              0.783
  Female                                                                     32 (57.1)                                30 (54.5)                                 
  **Employed (n, %)**                                                                                                                         
  No                                                                         40 (71.4)                                31 (56.4)                              0.988
  Yes                                                                        16 (28.6)                                24 (43.6)                                 
  **Marital status (n, %)**                                                                                                                   
  Married                                                                    46 (82.1)                                45 (81.8)                              0.965
  Unmarried                                                                  10 (17.9)                                10 (18.2)                                 
  **Cancer stage (n, %)**[b](#t1-fn2){ref-type="fn"}                                                                                          
  1                                                                          34 (60.8)                                38 (69.1)                              0.355
  2                                                                           5 (8.9)                                  4 (7.3)                                  
  3                                                                           5 (8.9)                                  5 (9.0)                                  
  4                                                                           5 (8.9)                                  4 (7.3)                                  
  Unknown                                                                    7 (12.5)                                  4 (7.3)                                  
  **Treatment status (n, %)**                                                                                                                 
  On treatment                                                               37 (66.1)                                39 (70.9)                              0.583
  Off treatment                                                              19 (33.9)                                16 (29.1)                                 
  **Current treatment (n, %)[c](#t1-fn3){ref-type="fn"}**                                                                                     
  Surgery                                                                    30 (81.1)                                31 (79.5)                              0.861
  Radiotherapy                                                                2 (5.4)                                  2 (5.1)                                  
  Target therapy                                                              3 (8.1)                                 5 (12.8)                                  
  Chemoradiotherapy                                                           2 (5.4)                                  1 (2.6)                                  
  **Days since diagnosis**                                                                                                                    
  Mean (SD)                                                               451.06 (636.82)                          456.53 (812.50)                           0.969
  Median                                                                      103.50                                   112.00                                   
  Range                                                                       7--2493                                 12--3465                                  

*P* values are based on the chi-square test for categorical variables and the *t* test for continuous variables.

In the chi-square test, cancer stages 2, 3, 4, and unknown were merged in one cell for comparison with cancer stage 1 to follow the statistical assumption and treat fewer than five cells. We present data from each original cell here for clarity.

In the chi-square test, radiotherapy, target therapy, and chemoradiotherapy were merged in one cell for comparison with surgery to follow the statistical assumption and treat fewer than five cells. We present data from each original cell here for clarity.

###### Per-protocol analysis: means, s.d., and differences between groups in outcomes over time according to generalised estimating equations adjusted for baseline r24 and moderate-intensity physical activity minutes (*N*=111)

                                                 **Baseline**   **3 Months**   **6 Months**                                               
  --------------------------------------------- -------------- -------------- -------------- ---- -------- ------- ---- -------- -------- ---------
  **PSQI**                                                                                                                                
  Walking exercise group                              56            9.25           4.55       47    6.26    3.14    43    6.49     3.71    0.001\*
  Usual care group[a](#t2-fn4){ref-type="fn"}         55            8.82           4.26       48    8.90    4.91    46    8.33     4.67        
  **TST**                                                                                                                                 
  Walking exercise group                              52           380.32         96.39       43   380.72   78.30   39   401.76   72.84    0.023\*
  Usual care group[a](#t2-fn4){ref-type="fn"}         54           395.06         88.21       41   375.94   92.40   40   369.29   107.21       
  **SE**                                                                                                                                  
  Walking exercise group                              52           88.94           9.67       43   89.14    8.69    39   88.18    10.78     0.779
  Usual care group[a](#t2-fn4){ref-type="fn"}         54           88.36          10.73       41   87.10    14.29   40   85.07    15.38        
  **SOL**                                                                                                                                 
  Walking exercise group                              52           27.14          40.48       43   28.29    31.93   39   22.15    23.00     0.427
  Usual care group[a](#t2-fn4){ref-type="fn"}         54           31.85          30.05       41   42.78    38.75   40   37.88    38.05        
  **WASO**                                                                                                                                
  Walking exercise group                              52           45.86          33.17       43   44.37    33.11   39   52.61    43.96     0.861
  Usual care group[a](#t2-fn4){ref-type="fn"}         54           50.56          45.30       41   53.53    54.53   40   63.92    66.42        
  **r24**                                                                                                                                 
  Walking exercise group                              52            0.42           0.14       42    0.43    0.17    39    0.47     0.15     0.572
  Usual care group[a](#t2-fn4){ref-type="fn"}         52            0.36           0.12       41    0.38    0.17    39    0.41     0.18        
  **I\<O**                                                                                                                                
  Walking exercise group                              52           94.68           7.31       42   94.95    5.54    39   96.63     2.98     0.709
  Usual care group[a](#t2-fn4){ref-type="fn"}         54           92.65           7.24       40   93.49    6.98    40   93.45     8.30        

Abbreviations: I\<O=in-bed less than out-of-bed dichotomy index; PSQI=Pittsburgh Sleep Quality Index; r24=24-h autocorrelation coefficient; SE=sleep efficiency; SOL=sleep onset latency; TST=total sleep time; WASO=wake after sleep onset.

Note: Generalised estimating equations were used for repeated measurements and the AR(1) correlation structure. All models were adjusted for age, sex, marital status, cancer stage and treatment, and variables significantly different at the baseline (r24 and moderate-intensity physical activity minutes).

\**P*\<0.05

Usual-care group is the reference group.

###### Subgroups of rest-activity rhythm analysis: Means, standard deviations, and differences between groups in outcomes over time according to generalised estimating equations

                                                  **Baseline**   **3 months**   **6 months**                                                         
  ---------------------------------------------- -------------- -------------- -------------- ---- -------- -------- ---- -------- -------- -------- ----------
  **Poor r24 (⩽0.30)**                                                                                                                               
  PSQI                                                                                                                                       9.395    0.009\*
   Walking exercise group                              11           11.64           3.91       9     6.56     3.09    10    6.70     3.06                 
   Usual-care group[a](#t3-fn4){ref-type="fn"}         18            9.39           3.42       17    9.06     4.88    16    8.75     4.55                 
  TST                                                                                                                                        14.382   0.001\*
   Walking exercise group                              11           348.55         82.85       7    357.62   58.60    8    413.35   70.56                 
   Usual-care group[a](#t3-fn4){ref-type="fn"}         18           421.09         108.74      16   364.18   112.98   15   374.23   132.19                
  **Favorable r24 (⩾0.46)**                                                                                                                          
  PSQI                                                                                                                                       9.395    0.009\*
   Walking exercise group                              21            7.57           4.82       19    6.11     2.89    16    5.63     3.67                 
   Usual-care group[a](#t3-fn4){ref-type="fn"}         12            8.25           5.08       11    8.73     5.12    11    8.73     4.17                 
  TST                                                                                                                                        14.382   0.001\*
   Walking exercise group                              21           405.23         91.96       18   397.54   65.88    16   404.00   89.65                 
   Usual-care group[a](#t3-fn4){ref-type="fn"}         12           394.36         51.89       8    389.90   40.92    8    386.65   77.99                 
  **Poor I\<O (⩽93.96)**                                                                                                                             
  PSQI                                                                                                                                       22.386   0.0001\*
   Walking exercise group                              11           12.27           4.17       9     7.00     3.57    7     8.00     3.83                 
   Usual-care group[a](#t3-fn4){ref-type="fn"}         23            8.35           3.79       21    8.24     4.92    19    8.37     4.81                 
  TST                                                                                                                                        4.713     0.095
   Walking exercise group                              11           327.45         113.76      8    359.02   112.56   7    368.29   77.43                 
   Usual-care group[a](#t3-fn4){ref-type="fn"}         23           391.15         102.75      20   349.35   89.98    19   349.93   116.93                
  **Favorable I\<O (⩾97.35)**                                                                                                                        
  PSQI                                                                                                                                       1.690     0.430
   Walking exercise group                              22            7.82           4.65       20    5.20     2.80    19    4.95     2.76                 
   Usual-care group[a](#t3-fn4){ref-type="fn"}         14            8.36           4.43       12    8.08     4.23    12    7.33     3.80                 
  TST                                                                                                                                        1.999     0.368
   Walking exercise group                              22           434.14         64.12       17   409.84   78.36    16   425.47   61.21                 
   Usual-care group[a](#t3-fn4){ref-type="fn"}         14           397.01         69.07       8    387.61   70.39    8    382.31   98.32                 

Abbreviations: I\<O=in-bed less than out-of-bed dichotomy index; PSQI=Pittsburgh Sleep Quality Index; r24=24-h autocorrelation coefficient; TST=total sleep time.

Note. Generalised estimating equations were used for repeated measurements and the AR(1) correlation structure. All models were adjusted for age, sex, marital status, cancer stage and treatment, and significant differences in demographic data, disease characteristics, and baseline outcomes in each subgroup.

\**P*\<0.05.

Usual-care group is the reference group.
